Theriva Biologics, Inc. Goodwill, Acquired During Period
Theriva Biologics, Inc. (TOVX) reported Goodwill, Acquired During Period of $6.76 million for the 12-month period ending 2022-12-31, per its 10-Q filed 2023-08-08.
Discontinued › Notes › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2023-08-08
- Theriva Biologics, Inc. goodwill, acquired during period for the quarter ending 2022-12-31 was $992.00K.
- Theriva Biologics, Inc. goodwill, acquired during period for the quarter ending 2022-09-30 was $0.00.
- Theriva Biologics, Inc. goodwill, acquired during period for the quarter ending 2022-06-30 was $0.00.
- Theriva Biologics, Inc. goodwill, acquired during period for the quarter ending 2022-03-31 was $5.76M.
| Period end | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 6 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month |
|---|---|---|---|---|
| 2022-12-31 | $992.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2023-08-08 | $992.00K derived: sum of 2 quarters · filed 2023-08-08 | $992.00K derived: sum of 3 quarters · filed 2023-08-08 | $6.76M 10-Q · filed 2023-08-08 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $5.76M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $5.76M 10-Q · filed 2022-08-11 | ||
| 2022-03-31 | $5.76M 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |